Navigational Bronchoscopy with Cryobiopsy for Diagnosis of ILD

Fernando Figueroa Rodriguez1, Asfar Ghauri1, Tony Abdo1

  • 1Interventional Pulmonary Program, Section of Pulmonary, Critical Care and Sleep Medicine, The Oklahoma City VA Health Care System, USA.

Case Reports in Pulmonology
|September 27, 2022
PubMed

Insights

Navigational bronchoscopy with lung cryobiopsy (LCB) offers a potentially safer method for diagnosing interstitial lung diseases (ILDs). This technique guided by CT angiography and ultrasound achieved diagnoses without complications in two patients.

Area of Science:

  • Pulmonology
  • Interventional Radiology

Background:

  • Interstitial lung diseases (ILDs) require accurate pathologic diagnosis.
  • Lung cryobiopsy (LCB) offers high diagnostic yield but carries significant complication risks.
  • Navigational bronchoscopy (NB) combined with advanced imaging can potentially mitigate these risks.

Observation:

  • Two cases of ILD diagnosis using NB-guided LCB are presented.
  • CT chest angiogram (CTA) with navigational protocol identified and premarked target areas.
  • Radial ultrasound (RU) and fluoroscopy guidance (FG) were used prior to cryobiopsy sampling.

Findings:

  • Both patients received a definitive diagnosis via NB-guided LCB.
  • Procedures were performed safely, with no reported complications.
  • Patients were discharged home post-procedure.

Implications:

  • NB-guided LCB may enhance the safety and diagnostic yield of ILD diagnosis.
  • Precise targeting of diseased lung areas with minimal vascularization is achievable.
  • Further large-scale trials are warranted to validate the benefits of this approach.
Abstract